Key result
Management of elevated blood pressure with lifestyle modifications and pharmacotherapy substantially reduces the risk of cardiovascular events, with current guidelines recommending a target of <130/80 mmHg.
This review highlights current ACC/AHA guidelines recommending a blood pressure goal of <130/80 mmHg for adults with hypertension, emphasizing lifestyle modifications and combination pharmacotherapy.
Affirms <130/80 mmHg targets for low-risk HTN; leaves open need for dedicated RCTs to refine thresholds.
Hypertension (HTN) affects 46% of the US adult population and plays a major role in cardiovascular disease (CVD). Approximately, there were 90,098 deaths in 2017 primarily attributed to high blood pressure (BP). Recent guidelines recommend screening all adults for HTN. Management of elevated BP substantially reduces the risk of heart failure, stroke, and myocardial infarction. Recommended lifestyle modifications include weight loss for overweight or obese patients, regular exercise, the dietary approached to stop hypertension (DASH) diet, reduced dietary sodium intake, and reduced alcohol intake. Most HTN patients will need at least 2 drugs to control BP. Current guidelines from the ACC and AHA state that a BP level goal of < 130/80mmHg for adults with confirmed HTN and without additional markers of increased atherosclerotic cardiovascular disease (ASCVD) risk may be acceptable.
No takes yet. Share an insight, caveat, or question.
Birudaraju et al. (2020) conducted a review in Hypertension. Antihypertensive therapy and lifestyle modifications was evaluated. Management of elevated blood pressure with lifestyle modifications and pharmacotherapy substantially reduces the risk of cardiovascular events, with current guidelines recommending a target of <130/80 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: